Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

ONVO RSS Feed
Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/21/2020 5:42:29 PM - Followers: 302 - Board type: Free - Posts Today: 0

WELCOME TO THE ORGANOVO BOARD


 
     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.

COMPANY PROFILE via YouTube
http://www.youtube.com/watch?feature=player_embedded&v=-A-uH15bQZw

 
ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014


IR and Media Contacts:
Investor Relations Contact: ir@organovo.com
Media Contact: media@organovo.com

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994


For all the latest company information, details, news, please visit http://www.organovo.com

 
Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:

Science

Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.

 

World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

 

NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.

http://www.invetech.com.au/portfolio/life-sciences/3d-bioprinter-world-first-print-human-tissue/
http://techli.com/2012/07/organovo-bioprinting/#.
https://www.youtube.com/watch?v=1O3c3pUg0L8 (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

ONVO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ONVO News: Annual Report (10-k) 05/28/2020 04:09:15 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 05/20/2020 06:29:12 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 05/20/2020 06:26:11 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 05/20/2020 06:23:31 PM
ONVO News: Current Report Filing (8-k) 05/20/2020 05:01:06 PM
News News Alert: Annual Report (10-k) 05/28/2020 04:09:15 PM
PostSubject
#10342   * * $ONVO Video Chart 05-21-2020 * * ClayTrader 05/21/20 05:42:29 PM
#10341   Shorty swing my way, until you fill the lojack 05/14/20 04:40:53 PM
#10340   But it wasn’t even pumped! It Magically went Johnnyvits 05/14/20 03:40:36 PM
#10339   Gap was filled. Looking north bound from here! lojack 05/14/20 03:29:01 PM
#10338   Pump and dump or short. aredrooster 05/14/20 03:15:31 PM
#10337   Gap just filled! In @.5601 average! Good luck everyone! lojack 05/14/20 03:15:08 PM
#10336   Does anyone have a clue what is going Johnnyvits 05/14/20 02:57:12 PM
#10335   * * $ONVO Video Chart 05-13-2020 * * ClayTrader 05/13/20 04:23:42 PM
#10334   I never expected a response. I believe Windbag1014 05/13/20 10:34:05 AM
#10333   Clay T is the Wuhan virus. boston127 05/13/20 10:26:15 AM
#10332   Does anyone know what’s going on at Organovo Johnnyvits 05/13/20 08:17:42 AM
#10331   Hi Clay, do you have some kind of Windbag1014 05/13/20 04:09:19 AM
#10330   * * $ONVO Video Chart 05-12-2020 * * ClayTrader 05/12/20 05:28:33 PM
#10329   * * $ONVO Video Chart 05-06-2020 * * ClayTrader 05/06/20 05:55:15 PM
#10328   * * $ONVO Video Chart 03-31-2020 * * ClayTrader 03/31/20 06:57:41 PM
#10327   Load the boat Trons 02/27/20 03:44:25 PM
#10326   It will certainly be interesting to see who RandolRocketman 02/18/20 05:04:57 PM
#10325   Not his company but former company, who wanted lucasreynard 01/16/20 01:38:43 PM
#10324   well put! starbuxsux 01/16/20 01:08:20 PM
#10323   I've never seen a press release where the ClearThinker 01/10/20 01:39:17 PM
#10322   It was going no where fast as it Profit 12/20/19 11:37:12 PM
#10321   Brazilian scientists 3D bioprint functional mini-livers Frenchy2016 12/19/19 09:59:11 AM
#10320   Good news! starbuxsux 12/17/19 10:33:50 AM
#10319   * * $ONVO Video Chart 12-16-2019 * * ClayTrader 12/16/19 06:11:21 PM
#10318   News: $ONVO Organovo and Tarveda Therapeutics Announce Definitive whytestocks 12/16/19 12:30:27 PM
#10317   I rode it for as long as I deadjim 11/20/19 04:46:42 PM
#10316   This tickets been around forever. Lot of broken tonyjh 11/18/19 09:35:31 PM
#10315   .48s and crickets. guess ihub doesn't like this ticker deadjim 11/18/19 11:46:48 AM
#10314   45s tickin on higher volume deadjim 11/15/19 03:32:30 PM
#10313   board is dead. why bother. lets see 43s deadjim 11/15/19 11:28:27 AM
#10312   .425s would be big ... just a short deadjim 11/12/19 01:18:25 PM
#10311   .39s up ;) stock1ace1 11/08/19 12:53:28 PM
#10310   Just needs a push through .42 highs deadjim 11/08/19 11:28:11 AM
#10309   What? Lol are you responding to your own messages? stock1ace1 11/08/19 10:42:41 AM
#10307   LMAO!!! LOOK AT THIS NOW !!! I TOLD YA!!!!! Pstats 11/07/19 12:29:54 PM
#10306   LMAO!!! POSSIBLE BUYOUT???WHERE WAS THE DIP COME REAL Pstats 11/07/19 09:44:10 AM
#10305   Selling before possible buyout crazy stock1ace1 11/05/19 11:03:30 AM
#10304   Short attack gonna get crushed ! stock1ace1 11/05/19 10:54:14 AM
#10303   still trading mid-range. own partials from .32, acts deadjim 11/05/19 10:04:08 AM
#10302   Watch for halt “pending news” :) could happen stock1ace1 11/04/19 10:43:03 AM
#10301   lets hope and without a split. makingitnow 11/03/19 01:57:12 PM
#10300   * * $ONVO Video Chart 11-01-2019 * * ClayTrader 11/01/19 05:24:28 PM
#10299   Very impressive list of Institutional Investors from my ddbl_our_buck 11/01/19 03:15:33 PM
#10298   Maybe A/h news on bid accept? stock1ace1 11/01/19 01:31:47 PM
#10297   Organovo Acknowledges Receipt of Proposal Source: GlobeNewswire Inc. Organovo stock1ace1 11/01/19 01:05:18 PM
#10296   3.5M short share...lets squeeze! Deeznuts 11/01/19 12:54:52 PM
#10295   Its getting ready to squeeze!!! Deeznuts 11/01/19 12:50:08 PM
#10294   Back to 1$ stock1ace1 11/01/19 11:49:35 AM
#10293   *** Takeover *** merger hod break stock1ace1 11/01/19 11:48:50 AM
#10292   On October 2, 2019, Organovo Holdings, Inc. (the stock1ace1 11/01/19 11:48:10 AM
PostSubject